[144] Confluent, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Confluent, Inc. (CFLT) reports a proposed sale of 953 common shares through Morgan Stanley Smith Barney with an aggregate market value of $17,964.05 and an approximate sale date of 08/28/2025. The filer acquired these shares on 09/26/2014 as an in-kind distribution post-IPO and lists total outstanding shares of 291,931,187.

The filing also discloses recent 10b5-1 sales on 06/05/2025: THE VISHRIA REVOCABLE TRUST sold 15,000 shares for $375,000 and THE KHAKAL TRUST sold 476 shares for $11,900. The signer certifies no undisclosed material adverse information and references reliance on trading-plan provisions where applicable.

Positive

• Regulatory compliance—the filing provides required Form 144 disclosures including broker, acquisition date, and certification
• Transparency on prior activity—recent 10b5-1 sales on 06/05/2025 are disclosed with amounts and proceeds

Negative

• Insider-related dispositions—trust accounts sold 15,476 shares in the past three months, which may attract investor attention despite being small versus total outstanding

Insights

Securities Analyst

TL;DR Routine Rule 144 notice; small proposed sale versus overall float and prior 10b5-1 activity disclosed.

This Form 144 documents a compliance notice for a proposed sale of 953 shares valued at $17,964.05, representing an immaterial fraction of the 291,931,187 shares outstanding. The filing properly states acquisition history (in-kind post-IPO distribution, 9/26/2014) and names the executing broker. The inclusion of recent 10b5-1 sales on 6/5/2025 totaling 15,476 shares provides additional context on prior insider-related dispositions. For investors, the filing is a transparency item rather than a signal of material change to company fundamentals.

Corporate Governance Expert

TL;DR Disclosure aligns with regulatory requirements; shows use of prearranged plans for orderly dispositions.

The notice includes the standard certification that the seller is unaware of undisclosed material adverse information and references Rule 10b5-1 planning where applicable. Naming the broker and providing acquisition details (in-kind distribution post-IPO) meet Form 144 expectations. The recent 10b5-1 sales by trusts are documented with gross proceeds, which aids governance transparency. There is no disclosure here of any unusual insider conduct or deviations from planned sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	953	17964.05	291931187	08/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/26/2014	In-kind distribution post IPO	Issuer			953	09/26/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for THE VISHRIA REVOCABLE TRUST 899 W. EVELYN AVENUE MOUNTAIN VIEW CA 94041	Common	06/05/2025	15000	375000.00
10b5-1 Sales for THE KHAKAL TRUST 899 W. EVELYN AVENUE MOUNTAIN VIEW CA 94041	Common	06/05/2025	476	11900.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Confluent's (CFLT) Form 144 report?

The filing reports a proposed sale of 953 common shares valued at $17,964.05, with an approximate sale date of 08/28/2025.

Who is the broker listed on the Form 144 for CFLT?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza.

When were the shares to be sold originally acquired?

The 953 shares were acquired on 09/26/2014 as an in-kind distribution post-IPO.

Were there recent insider or trust sales disclosed for CFLT?

Yes, two 10b5-1 sales on 06/05/2025: THE VISHRIA REVOCABLE TRUST sold 15,000 shares for $375,000; THE KHAKAL TRUST sold 476 shares for $11,900.

How many shares does Confluent have outstanding per the filing?

The filing lists 291,931,187 shares outstanding.